PLMSCs transplantation in Type 1 diabetes patients
Preliminary report phase 1 clinical trial using a xeno-free & GMP compliant protocol with Human Platelet Lysate Madani et al. reported the short term safety of Placenta derived Mesenchymal Stem Cells (PLMSCs) transplanted in 4 children (Type 1 Diabetes Mellitus patients (T1DM)). The manufacturing of PLMSCs to the
